Mohan, M., Becnel, M. R., Shah, U. A., Dong, H., Gundarlapalli, S., Peterson, T., Orozco, J. S., Horowitz, S., Chhabra, S., Dhakal, B., Thanendrarajan, S., Radhakrishnan, S. V., Al Hadidi, S., Tan, C., Mailankody, S., Hultcrantz, M., Korde, N., Hassoun, H., Lesokhin, A. M., Thomas, S. K., Patel, K. K., Manasanch, E. E., Weber, D. M., Szabo, A., Kaufman, G. P., Lee, H. C., Zangari, M., van Rhee, F., Usmani, S. Z., D'Souza, A., Orlowski, R. Z., & Schinke, C. (2022). clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience. American journal of hematology, 97(7), E276–E280. http://access.bl.uk/ark:/81055/vdc_100156715926.0x00003c